A top official at the Office of the Special Prosecutor (OSP), Sammy Darko, has rubbished the medical report released by the legal team of former Finance Minister Ken Ofori-Atta, describing it as a calculated move designed to sway public opinion rather than aid legitimate investigations.
Speaking to Citi News, Darko, who is the Director of Strategy, Research and Communication at the OSP, expressed strong skepticism about the authenticity and timing of the medical document, which was recently shared with sections of the media including Asaase Radio.
“If you have this and you won’t show this to the SP or the office, but you can share it with Asaase Radio—fake afterthought,” he said bluntly, questioning the motive behind the public circulation of the letter while the Office had not officially received it.
His comments come in the wake of a leaked letter from the Mayo Clinic in the United States, purportedly authored by a medical officer overseeing Ofori-Atta’s treatment. The letter stated that the former minister had been diagnosed with prostate cancer and would be undergoing surgery in June 2025.
According to the document, “The former finance minister has undergone an MR-guided biopsy and has been diagnosed with prostate cancer. Surgical intervention has been deemed necessary after the testing and MRI biopsy procedure in March 2025, as I indicated in my February letter.
This surgical procedure has been scheduled for June with Dr. Paras Shah of the Department of Urology.”
The document has sparked controversy as it surfaced in the public domain while the OSP continues its investigation into Ofori-Atta. The Office had recently announced efforts to locate and possibly extradite the former minister, citing a lack of cooperation despite ongoing probes.
Darko’s sharp dismissal of the report reflects a growing rift between the OSP and Ofori-Atta’s legal team, with the latter arguing that their client is not fleeing justice but seeking urgent medical attention abroad.
They have also reportedly offered to cooperate with the OSP virtually during the treatment period.
However, the OSP appears unconvinced, viewing the move as a public relations tactic rather than a genuine attempt at transparency.
With the next court hearing scheduled for June 18, 2025, all eyes will be on how both sides proceed—and whether the report will bear any weight in the legal process ahead.
